More than Half of U.S Physicians Recommend at Least One Complementary Health Approach to Patients

Complementary Health

A new study has shown that more than half (53.1%) of office-based physicians in the U.S., across specialty areas, recommended at least one complementary health approach (CHA) to their patients during the previous 12 months, with female physicians (63.2%) more likely to recommend a CHA than male physicians (49.3%). ThisRead

Can $1-Million to Kick-Start a New RAND Project to Revitalize Research in Chiropractic, Acupuncture and Naturopathic Colleges?

research

The beginning of the RAND project proposal captures dimensions of an awful tend: “The future of research in the Complementary and Integrative Health (CIH) institutions is in jeopardy. A number of CIH colleges and universities are losing their research departments due to lack of consistent funding and the understandable inabilityRead

9 Ways to Earn Your Patient’s Lifetime Value

lifetime value

I retract a previous post: building a subscriber list isn’t the foremost marketing tactic for growing an integrative medicine practice or brand. Unequivocally, that distinction belongs to securing customer loyalty, in turn, driving patient lifetime value. According to Wikipedia, customer lifetime value—what we’ll refer to as patient lifetime value (PLV)—predictsRead

Biological Clock Plays Crucial Role in Healing from Surgery

healing

If you prescribe an anti-inflammatory for your patients after knee, hip or shoulder surgery, you may want to suggest they take them in the morning or at noon, but not at night. A McGill-led study shows, for the first time, that circadian clock genes are involved in healing from surgery.Read

Echosens Aligns with Fatty Liver Foundation to Accelerate Screening for Undiagnosed Nonalcoholic Fatty Liver Disease

fatty liver

Echosens, a high-technology company offering the FibroScan family of products, is proud to support the Fatty Liver Foundation (FLF), a non-profit organization dedicated to fighting fatty liver disease and advocating for ongoing screening of undiagnosed nonalcoholic fatty liver disease (NAFLD) and its more severe form nonalcoholic steatohepatitis (NASH). FLF isRead